1. Home
  2. SBFM vs ISPC Comparison

SBFM vs ISPC Comparison

Compare SBFM & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • ISPC
  • Stock Information
  • Founded
  • SBFM 2006
  • ISPC 2009
  • Country
  • SBFM United States
  • ISPC United States
  • Employees
  • SBFM N/A
  • ISPC N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • ISPC Precision Instruments
  • Sector
  • SBFM Health Care
  • ISPC Health Care
  • Exchange
  • SBFM Nasdaq
  • ISPC Nasdaq
  • Market Cap
  • SBFM 6.7M
  • ISPC 6.9M
  • IPO Year
  • SBFM N/A
  • ISPC 2021
  • Fundamental
  • Price
  • SBFM $1.67
  • ISPC $0.76
  • Analyst Decision
  • SBFM Strong Buy
  • ISPC
  • Analyst Count
  • SBFM 1
  • ISPC 0
  • Target Price
  • SBFM $7.00
  • ISPC N/A
  • AVG Volume (30 Days)
  • SBFM 2.2M
  • ISPC 504.9K
  • Earning Date
  • SBFM 11-12-2025
  • ISPC 11-14-2025
  • Dividend Yield
  • SBFM N/A
  • ISPC N/A
  • EPS Growth
  • SBFM N/A
  • ISPC N/A
  • EPS
  • SBFM N/A
  • ISPC N/A
  • Revenue
  • SBFM $36,341,741.00
  • ISPC $5,908,088.00
  • Revenue This Year
  • SBFM $21.12
  • ISPC $35.93
  • Revenue Next Year
  • SBFM $44.89
  • ISPC N/A
  • P/E Ratio
  • SBFM N/A
  • ISPC N/A
  • Revenue Growth
  • SBFM 19.22
  • ISPC N/A
  • 52 Week Low
  • SBFM $1.17
  • ISPC $0.64
  • 52 Week High
  • SBFM $3.90
  • ISPC $5.48
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 45.08
  • ISPC 40.08
  • Support Level
  • SBFM $1.81
  • ISPC $0.75
  • Resistance Level
  • SBFM $2.13
  • ISPC $0.86
  • Average True Range (ATR)
  • SBFM 0.16
  • ISPC 0.07
  • MACD
  • SBFM -0.04
  • ISPC 0.01
  • Stochastic Oscillator
  • SBFM 6.10
  • ISPC 24.41

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Share on Social Networks: